Zealand Pharma aims high in obesity market with a focus beyond weight loss

Zealand Pharma has a sharp focus on obesity treatment, but also has its eye on another indication that’s getting a lot of attention these days: nash. 
Photo: Stine Bidstrup
Photo: Stine Bidstrup
af marketwire

Zealand Pharma multiple shots at competing for a place in the growing billion-dollar market for weight loss products. The goal for the portfolio of upcoming weight loss products is not only to show significant weight loss, but just as importantly to show an effect on other complications of obesity.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
  • Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
    Must contain at least 2 characters
    Must contain at least 2 characters

    Get full access for you and your coworkers

    Start a free company trial today

    Share article

    Sign up for our newsletter

    Stay ahead of development by receiving our newsletter on the latest sector knowledge.

    Newsletter terms

    Front page now

    Further reading